ArticleArXiv2025
Automated grading and staging of ovarian cancer using deep learning on the transmission optical microscopy bright-field images of thin biopsy tissue samples.
Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Ovarian cancer remains a challenging malignancy to diagnose and manage, with prognosis heavily dependent on the stage at detection. Accurate grading and staging, primarily based on histopathological examination of biopsy tissue samples, are crucial for treatment planning and predicting outcomes. However, this manual process is time-consuming and subject to inter-observer variability among pathologists. The increasing volume of digital histopathology slides necessitates the development of robust, automated methods to assist in this critical diagnostic step for ovarian cancer. (Methods) This study presents a deep learning framework for the automated prediction of ovarian cancer stage (classified into five categories: 0, I, II, III, IV) using routine histopathological images. We employed a transfer learning approach, fine-tuning a ResNet-101 convolutional neural network pre-trained on ImageNet. The training process incorporated comprehensive data augmentation, weighted random sampling, and class weighting to address dataset characteristics. Hyperparameter optimization for learning rate, dropout rate, and weight decay was performed using a genetic algorithm to enhance model performance and generalization. (Results) Evaluated on an independent test set of ovarian thin tissue brightfield images, the developed model achieved a high overall classification accuracy of 97.62%.
Indexed as
Identifiers
40463694PMC12133081What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.